Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1996-10-30
1999-04-06
Feisee, Lila
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
435 691, 435325, 4353201, C12N 1512, C12N 1563, C12N 510
Patent
active
058920145
ABSTRACT:
Disclosed are cDNAs and genomic DNAs encoding protease-activated receptor 3 (PAR3) from mouse and human, and the recombinant polypeptides expressed from such cDNAs. The recombinant receptor polypeptides, receptor fragments and analogs expressed on the surface of cells are used in methods of screening candidate compounds for their ability to act as agonists or antagonists to the effects of interaction between thrombin and PAR3. Agonists are used as therapeutics to treat wounds, thrombosis, atherosclerosis, restenosis, inflammation, and other thrombin-activated disorders. Antagonists are used as therapeutics to control blood coagulation and thereby treating heart attack and stroke. Antagonists mediate inflammatory and proliferative responses to injury as occur in normal wound healing and variety of diseases including atherosclerosis, restenosis, pulmonary inflammation (ARDS) and glomerulosclerosis. Antibodies specific for a protease-activated receptor 3 (or receptor fragment or analog) and their use as a therapeutic are also disclosed.
REFERENCES:
patent: 5256766 (1993-10-01), Coughlin
patent: 5686597 (1997-11-01), Coleman et al.
Amatrude III, T.T., et al. (1991) "G.alpha.16, a G protein .alpha.subunit specifically expressed in hematopoietic cells," Proc. Natl. Acad. Sci. 88:5587-91.
Connolly, A., et al. (1996) "Role of the thrombin receptor in development and evidence for a second receptor," Nature 381:516-519.
Ishii, K., et al. (1993) "Kinetics of thrombin receptor cleavage on intact cells," J. Biol. Chem. 268:9780-9786.
Ishii, K., et al. (1995) "Determinants of thrombin receptor cleavage," J. Biol. Chem. 270:16435-16440.
Julius, D., et al. (1988) "Molecular characterization of a functional cDNA encoding the serotonin 1c receptor" Science 241:558-564.
Liu, L., et al. (1991) "The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity," J. Biol. Chem. 266:16977-16980.
Mathews, I.I., et al. (1994) "Crystallographic structures of thrombin complexed with thrombin receptor peptides: Existence of expected and novel binding modes," Biochem. 33:3266-3279.
Nonevicz, T., et al. (1996) "Thrombin receptor activating mutations," J. Biol. Chem. 271:702-706.
Nystedt, S., et al. (1994) "Molecular cloning of a potential proteinase activated receptor," Proc. Natl. Acad. Sci. USA, 91:9208-9212.
Scarborough, R.M., et al. (1992) "Tethered ligand agonist peptides," J. Biol. Chem. 267:13146-13149.
Soifer, S.J., et al. (1993) "Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development," Am. J. Pathol. 144:60-69.
Vu, T.-K.H., et al. (1991) "Molecular cloning of a functional thrombin receptor reveals a novel protcolytic mechanism of receptor activation," Cell 64:1057-1068.
Vu, T.-K.H., et al. (1991) "Domains specifying thrombin-receptor interaction," Nature 353:674-677.
Connolly Andrew
Coughlin Shaun R.
Ishihara Hiroaki
Feisee Lila
Pak Michael
The Regents of the University of California
LandOfFree
DNA encoding a protease-activated receptor 3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding a protease-activated receptor 3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding a protease-activated receptor 3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1372423